Clinical Trials Directory

Trials / Unknown

UnknownNCT00538408

Whole Body Magnetic Resonance Angiography in Ischemic Patients

Whole Body Magnetic Resonance Angiography in Patients With Symptomatic Peripheral Ischemia

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Copenhagen University Hospital at Herlev · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To investigate the diagnostic performance of whole body magnetic resonance angiography (WB-MRA) using two different magnetic resonance contrast agents.

Detailed description

Atherosclerosis of the lower leg arteries is a common disease. Patients with this condition has symptoms of ischemia, for instance intermittent claudication (pain during exercise). Diagnosis of atherosclerosis in the legs is normally done with an interventional x-ray-based angiography (DSA- digital subtraction angiography). This is uncomfortable for the patient, and associated with risks of complications (bleeding, vascular damage, embolism).A novel approach to diagnosing atherosclerosis is the use of magnetic resonance angiography. A variant of this is the whole body magnetic resonance angiography(WB-MRA), that produce a picture of the arteries in almost the whole body (excluding the coronary arteries). WB-MRA has a number of advantages compared to DSA. It does not use ionizing radiation, is not invasive, uses a contrast medium with fewer side affects and finally gives a covers a great deal of the arteries in the body. This study will compare WB-MRA with DSA in patients with symptoms of peripheral atherosclerosis in the lower legs. We will investigate 2 different contrast agents used for WB-MRA. The patients will be randomized to receive either the contrast medium Dotarem or the contrast medium Vasovist. In both groups we will compare the results of WB-MRA with DSA.

Conditions

Interventions

TypeNameDescription
PROCEDUREWhole body magnetic resonance angiography (dotarem)
DEVICEWhole body magnetic resonance angiography (vasovist)

Timeline

Start date
2007-09-01
Completion
2010-01-01
First posted
2007-10-02
Last updated
2009-02-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00538408. Inclusion in this directory is not an endorsement.